Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease.
Nicolau, José C; Baracioli, Luciano M; Giugliano, Robert P.
Expert Opin Pharmacother
; 19(9): 1013-1019, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29893152
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial.
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects.
Ticagrelor induced systemic inflammatory response syndrome.
Ticagrelor: agonising over its mechanisms of action.
Letter by Downey and Cohen Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Letter by Fernandez-Jimenez et al Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Response by Vilahur et al to Letters Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?